Business Context and Reporting Period
This Form 8-K Current Report, dated September 29, 2020, details material definitive agreements entered into by JetBlue Airways Corporation with the United States Department of the Treasury under the CARES Act. The filing addresses financing activities and payroll support received during the period ending September 30, 2020.
Key Financial Metrics and Agreements
- CARES Act Loan Facility: Entered into a loan agreement for an aggregate principal amount of up to $1,140,000,000. On September 29, 2020, JetBlue drew $115,000,000.
- Loan Terms: Borrowings bear interest at LIBOR plus a margin of 2.75% per annum (with a 0% floor). Maturity is five years from the initial borrowing date.
- Collateral Requirements: Obligations are secured by liens on eligible aircraft, loyalty program assets, and accounts. The company must maintain a minimum collateral coverage ratio of 1.6 to 1.0.
- Liquidity Covenants: The company is required to maintain unrestricted cash and unused revolving credit commitments aggregating not less than $550 million.
- Additional Payroll Support: Received a payment of $27.1 million on September 30, 2020, consisting of a $19.0 million grant and an $8.1 million increase in the principal of an existing promissory note.
Material Changes and Equity Issuances
In connection with the financing activities, JetBlue issued warrants to the Treasury, representing a material change in its capital structure:
- CARES Act Warrants: Issued warrants to purchase 1,210,526 shares of common stock in connection with the $115 million loan drawing.
- Additional PSP Warrants: Issued warrants to purchase an additional 85,540 shares of common stock in consideration for the Additional Payroll Support Payment.
- Exercise Price: All warrants have an exercise price of $9.50 per share.
- Warrant Terms: Warrants expire five years after issuance, include anti-dilution provisions, and have no voting rights. Treasury has agreed not to vote shares issued upon exercise.
Guidance, Risks, and Contingencies
The filing outlines significant operational and financial restrictions imposed by the new agreements:
- Covenants: The Loan Agreement includes affirmative and negative covenants restricting the disposal of collateral, mergers, asset sales, incurrence of additional indebtedness, and payment of dividends.
- Default and Prepayment: Events of default may accelerate loan repayment. Additionally, certain change of control events will require full prepayment of the loans.
- Collateral Maintenance: Failure to meet the minimum collateral coverage ratio requires the company to provide additional collateral or repay loans to maintain compliance.
Investor Verification Checklist
- Verify the total outstanding principal under the CARES Act Loan Agreement and the Payroll Support Program Promissory Note.
- Confirm the company's current unrestricted cash balance and unused revolving credit commitments to ensure compliance with the $550 million liquidity covenant.
- Review the appraised value of the pledged collateral (aircraft, loyalty assets) to assess the 1.6 to 1.0 coverage ratio compliance.
- Monitor the dilution impact of the 1,296,066 total warrants issued to the Treasury at the $9.50 exercise price.
- Check for any subsequent filings regarding the registration of the CARES Act Warrants and Underlying Common Stock on a "shelf" registration statement.